Skip to content

Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol

C104H121BrN16O18Pd — CID 157416105

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACacetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol
SMILESC=CCC(C)O.CC(=O)O.CC(=O)O.CCOC(=O)C[C@@H](c1ccc(OC)nc1)n1cc2ccc(/C=C/CC(C)O)cc2n1.CCOC(=O)C[C@@H](c1ccc(OC)nc1)n1cc2ccc(Br)cc2n1.COc1ccc([C@H](CC(=O)O)n2cc3ccc(CCCc4ccc5c(n4)NCCC5)cc3n2)cn1.COc1ccc([C@H](CC(=O)O)n2cc3ccc(CCc4cc5c(nc4C)NCCC5)cc3n2)cn1.[Pd]
InChIInChI=1S/2C27H29N5O3.C23H27N3O4.C18H18BrN3O3.C5H10O.2C2H4O2.Pd/c1-17-19(13-20-4-3-11-28-27(20)30-17)7-5-18-6-8-22-16-32(31-23(22)12-18)24(14-26(33)34)21-9-10-25(35-2)29-15-21;1-35-25-12-10-20(16-29-25)24(15-26(33)34)32-17-21-8-7-18(14-23(21)31-32)4-2-6-22-11-9-19-5-3-13-28-27(19)30-22;1-4-30-23(28)13-21(18-10-11-22(29-3)24-14-18)26-15-19-9-8-17(12-20(19)25-26)7-5-6-16(2)27;1-3-25-18(23)9-16(12-5-7-17(24-2)20-10-12)22-11-13-4-6-14(19)8-15(13)21-22;1-3-4-5(2)6;2*1-2(3)4;/h6,8-10,12-13,15-16,24H,3-5,7,11,14H2,1-2H3,(H,28,30)(H,33,34);7-12,14,16-17,24H,2-6,13,15H2,1H3,(H,28,30)(H,33,34);5,7-12,14-16,21,27H,4,6,13H2,1-3H3;4-8,10-11,16H,3,9H2,1-2H3;3,5-6H,1,4H2,2H3;2*1H3,(H,3,4);/b;;7-5+;;;;;/t2*24-;16?,21-;16-;;;;/m0000..../s1
InChIKeyWKKHSSYOYIJWPL-YCXWPBOQSA-N
MW2069.53 g/mol
LogP17.42
Rot. Bonds34

About Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol

Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol (PubChem CID 157416105) has the molecular formula C104H121BrN16O18Pd and a molecular weight of 2069.53 g/mol. Its IUPAC name is acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol.

Molecular Properties

Compound NameAcetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol
PubChem CID157416105
Molecular FormulaC104H121BrN16O18Pd
Molecular Weight2069.53 g/mol
Exact Mass2066.73
IUPAC Nameacetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol
SMILESC=CCC(C)O.CC(=O)O.CC(=O)O.CCOC(=O)C[C@@H](c1ccc(OC)nc1)n1cc2ccc(/C=C/CC(C)O)cc2n1.CCOC(=O)C[C@@H](c1ccc(OC)nc1)n1cc2ccc(Br)cc2n1.COc1ccc([C@H](CC(=O)O)n2cc3ccc(CCCc4ccc5c(n4)NCCC5)cc3n2)cn1.COc1ccc([C@H](CC(=O)O)n2cc3ccc(CCc4cc5c(nc4C)NCCC5)cc3n2)cn1.[Pd]
InChIInChI=1S/2C27H29N5O3.C23H27N3O4.C18H18BrN3O3.C5H10O.2C2H4O2.Pd/c1-17-19(13-20-4-3-11-28-27(20)30-17)7-5-18-6-8-22-16-32(31-23(22)12-18)24(14-26(33)34)21-9-10-25(35-2)29-15-21;1-35-25-12-10-20(16-29-25)24(15-26(33)34)32-17-21-8-7-18(14-23(21)31-32)4-2-6-22-11-9-19-5-3-13-28-27(19)30-22;1-4-30-23(28)13-21(18-10-11-22(29-3)24-14-18)26-15-19-9-8-17(12-20(19)25-26)7-5-6-16(2)27;1-3-25-18(23)9-16(12-5-7-17(24-2)20-10-12)22-11-13-4-6-14(19)8-15(13)21-22;1-3-4-5(2)6;2*1-2(3)4;/h6,8-10,12-13,15-16,24H,3-5,7,11,14H2,1-2H3,(H,28,30)(H,33,34);7-12,14,16-17,24H,2-6,13,15H2,1H3,(H,28,30)(H,33,34);5,7-12,14-16,21,27H,4,6,13H2,1-3H3;4-8,10-11,16H,3,9H2,1-2H3;3,5-6H,1,4H2,2H3;2*1H3,(H,3,4);/b;;7-5+;;;;;/t2*24-;16?,21-;16-;;;;/m0000..../s1
InChIKeyWKKHSSYOYIJWPL-YCXWPBOQSA-N
XLogP17.42
TPSA451.86 Ų
H-Bond Donors8
H-Bond Acceptors30
Rotatable Bonds34
Heavy Atoms140
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002069.53
LogP ≤ 517.42
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol?
The IUPAC name of Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol (CID 157416105) is acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol.
What is the SMILES notation for Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol?
The canonical SMILES for Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol is C=CCC(C)O.CC(=O)O.CC(=O)O.CCOC(=O)C[C@@H](c1ccc(OC)nc1)n1cc2ccc(/C=C/CC(C)O)cc2n1.CCOC(=O)C[C@@H](c1ccc(OC)nc1)n1cc2ccc(Br)cc2n1.COc1ccc([C@H](CC(=O)O)n2cc3ccc(CCCc4ccc5c(n4)NCCC5)cc3n2)cn1.COc1ccc([C@H](CC(=O)O)n2cc3ccc(CCc4cc5c(nc4C)NCCC5)cc3n2)cn1.[Pd].
What is the InChIKey of Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol?
The InChIKey is WKKHSSYOYIJWPL-YCXWPBOQSA-N. The full InChI is InChI=1S/2C27H29N5O3.C23H27N3O4.C18H18BrN3O3.C5H10O.2C2H4O2.Pd/c1-17-19(13-20-4-3-11-28-27(20)30-17)7-5-18-6-8-22-16-32(31-23(22)12-18)24(14-26(33)34)21-9-10-25(35-2)29-15-21;1-35-25-12-10-20(16-29-25)24(15-26(33)34)32-17-21-8-7-18(14-23(21)31-32)4-2-6-22-11-9-19-5-3-13-28-27(19)30-22;1-4-30-23(28)13-21(18-10-11-22(29-3)24-14-18)26-15-19-9-8-17(12-20(19)25-26)7-5-6-16(2)27;1-3-25-18(23)9-16(12-5-7-17(24-2)20-10-12)22-11-13-4-6-14(19)8-15(13)21-22;1-3-4-5(2)6;2*1-2(3)4;/h6,8-10,12-13,15-16,24H,3-5,7,11,14H2,1-2H3,(H,28,30)(H,33,34);7-12,14,16-17,24H,2-6,13,15H2,1H3,(H,28,30)(H,33,34);5,7-12,14-16,21,27H,4,6,13H2,1-3H3;4-8,10-11,16H,3,9H2,1-2H3;3,5-6H,1,4H2,2H3;2*1H3,(H,3,4);/b;;7-5+;;;;;/t2*24-;16?,21-;16-;;;;/m0000..../s1.
What are the key properties of Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol?
Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol has a molecular weight of 2069.53 g/mol, XLogP of 17.42, 34 rotatable bonds, 8 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for Acetic acid;ethyl (3S)-3-(6-bromoindazol-2-yl)-3-(6-methoxy-3-pyridinyl)propanoate;ethyl (3S)-3-[6-[(E)-4-hydroxypent-1-enyl]indazol-2-yl]-3-(6-methoxy-3-pyridinyl)propanoate;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[2-(2-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)ethyl]indazol-2-yl]propanoic acid;(3S)-3-(6-methoxy-3-pyridinyl)-3-[6-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]indazol-2-yl]propanoic acid;palladium;pent-4-en-2-ol is sourced from PubChem (CID 157416105), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.